The seven policies, and whose claims each one governs
| Contractor and policy | States and territories | Rechecking a low level |
|---|---|---|
| CGS, L33996 (August 6, 2026) | Kentucky, Ohio | After deficiency, only to confirm replacement; then "annual testing may be appropriate" |
| Wellpoint Federal, L37535 (April 1, 2026) | Illinois, Minnesota, Wisconsin, Connecticut, Maine, Massachusetts, New Hampshire, New York, Rhode Island, Vermont | Stable at 20 to 50 ng/mL: repeat "often unnecessary"; under 20 or over 60: may be reimbursed until normal |
| Palmetto GBA, L39391 (January 1, 2026) | Alabama, Georgia, Tennessee, North Carolina, South Carolina, Virginia, West Virginia | Under 30 ng/mL: one repeat after 12 weeks of supplements, one more within a rolling 12 months; "The medical record must reflect that the beneficiary has been compliant with supplementation"; "Annual testing should be rare" |
| WPS, L34658 (August 28, 2025) | Iowa, Kansas, Missouri, Nebraska, Indiana, Michigan | Up to 4 a year for deficiency, rickets or osteomalacia; once a year for other conditions |
| Noridian, L36692 (August 14, 2025) | Alaska, Arizona, California, Hawaii, Idaho, Montana, Nevada, North Dakota, Oregon, South Dakota, Utah, Washington, Wyoming, American Samoa, Guam, Northern Mariana Islands | Same wording as Wellpoint Federal |
| First Coast, L33771 (October 29, 2020) | Florida, Puerto Rico, U.S. Virgin Islands | No more than three a year; once a year after levels reach normal |
| Novitas, L34914 (July 1, 2020) | Arkansas, Colorado, Delaware, District of Columbia, Louisiana, Maryland, Mississippi, New Jersey, New Mexico, Oklahoma, Pennsylvania, Texas; for Part B, also Arlington and Fairfax counties and the cities of Alexandria, Fairfax and Falls Church in Virginia | Up to 3 a year (a general vitamin assay policy) |
Which reasons pass: the code list and the policy text
Codes like E55.9 are the reason written on the order; five-digit codes like 82306 name the test.
Each policy has a billing article listing the diagnosis codes that "support medical necessity" for the test, and an LCD text that names the conditions. Passing the list is not enough on its own; CGS's article says "The correct use of an ICD-10-CM code listed below does not assure coverage of a service. The service must be reasonable and necessary in the specific case and must meet the criteria specified in this determination." We compared the seven code lists for the standard 25-hydroxy test (code 82306), code by code, from 183 codes (CGS) to 848 (WPS), and read each text for the same conditions.
| Reason on the order | On the code list | Named in the policy text |
|---|---|---|
| Vitamin D deficiency (E55.9) | All seven; Wellpoint Federal and Noridian say the code is for deficiency from a condition on their list and "should not be used for any other indication" | On its own: Palmetto GBA and WPS ("hypovitaminosis D"). To monitor replacement therapy: CGS, WPS, First Coast. Only on replacement therapy "related to a condition listed above": Wellpoint Federal, Noridian, Palmetto GBA |
| Age-related osteoporosis (M81.0) | All seven | CGS, Palmetto GBA, WPS, First Coast; Wellpoint Federal and Noridian only with a T-score of -2.5 or lower, a fragility fracture, a FRAX score above their thresholds, or before starting a bisphosphonate |
| Osteopenia (M85.8 codes) | All seven (Palmetto GBA's list has no unspecified-site code) | CGS, Palmetto GBA, WPS, First Coast; not Wellpoint Federal or Noridian, though Wellpoint's article tells coders which codes to use for it |
| BMI of 30 or more (Z68.30 and higher) | All seven | Obesity: CGS, Palmetto GBA (BMI of 30 or more), WPS, First Coast; not Wellpoint Federal or Noridian |
| Kidney disease, stage 3 or worse (N18.3 to N18.6) | All seven | All six texts that list conditions |
| Long-term steroid use (Z79.52) | All except CGS | Palmetto GBA, WPS, First Coast (medicines that lower vitamin D levels) |
| Status after weight-loss surgery (Z98.84) | Palmetto GBA, WPS, First Coast, Novitas | Palmetto GBA, WPS ("gastric bypass"), First Coast |
| Psoriasis (L40 codes) | Wellpoint Federal, WPS, Noridian, First Coast, Novitas | WPS, First Coast |
| Fibromyalgia (M79.7) | WPS, First Coast, Novitas | WPS |
| Obesity, unspecified (E66.9) | None; the BMI code is what the lists accept | Not applicable |
| Fatigue (R53.83) or malaise (R53.81) | None | None |
| Routine adult exam (Z00.00, Z00.01) | None | None |
| Any screening code (Z13) | None | None; six texts rule out screening, and First Coast's is silent |
| Falls or fall risk (R29.6, Z91.81) | None | None |
Where the two layers disagree, as at Wellpoint Federal and Noridian for obesity and osteopenia, a claim can pass the automated check and still fail if the record is reviewed against the text. That is our reading of how the two fit together, based on the article wording above; ask the ordering office which reason it will use and whether it fits the policy text as well as the list.
Which region's policy is yours
It may not be your home state's. CMS's claims manual says jurisdiction for an independent laboratory's claims "normally lies with the carrier serving the area in which the laboratory test is performed." It adds two exceptions: "there are some situations where a regional or national lab chain jurisdiction is with a single carrier," and when a lab sends your sample on to another lab in a different region for more tests, "the carrier servicing the referring laboratory retains jurisdiction for services performed by the other laboratory." The simplest check is to ask the lab which Medicare contractor processes its claims.
What to ask before the blood is drawn
- What reason will be on the order? If it is fatigue, "annual labs" or a routine physical, expect a denial in every region.
- Is there a true covered reason? Kidney disease, osteoporosis, malabsorption or a parathyroid problem may already be in your record; check the row for your region above. Tell the clinician about conditions that apply; never ask for one that does not.
- Which test is ordered? The 25-hydroxy test (Medicare pays $29.60) is the standard one. For the 1,25-dihydroxy test ($38.50), Wellpoint Federal, Palmetto GBA, WPS and Noridian keep separate, shorter code lists (17 to 124 codes, against 362 to 848 for the standard test); the CGS and First Coast articles cover the 25-hydroxy test only, and First Coast's text says the 1,25 test "is primarily indicated during patient evaluations for hypercalcemia and renal failure"; Novitas uses one list for both.
- Is this a recheck of a low level? Every policy allows rechecks to confirm treatment is working, but Wellpoint Federal, Noridian and Palmetto GBA tie them to a condition on their list, and Palmetto expects 12 weeks of supplements first, with records showing you took them.
If the lab expects a denial, it should give you an Advance Beneficiary Notice before the draw; our guide to the Medicare ABN for lab tests explains the three choices. Paying cash instead? Our vitamin D price comparison compares three sellers' prices.
Should you be tested at all?
For most adults, the coverage rule and the medical advice point the same way. The USPSTF (April 13, 2021) found the evidence insufficient to assess screening adults without symptoms, and the Endocrine Society's 2024 guideline "suggests against routine 25(OH)D testing in the absence of established indications." Our guide to who needs vitamin D supplements covers the groups that guideline does recommend supplements for, which is a different question from testing.
What we checked and what we did not
We read the seven current local coverage determinations and their billing articles through the CMS Medicare Coverage Database (the coded lists and article notes from its public API), CMS's twelve A/B contractor jurisdiction pages, chapter 1 of the claims manual, the 2026 lab fee schedule, the USPSTF statement and the Endocrine Society abstract on PubMed (title checked). We compared code lists for the 25-hydroxy test and counted, but did not compare, the separate 1,25-dihydroxy lists. We did not test how any contractor's claim system applies its lists or limits, and Medicare Advantage plans may set their own rules.
Wellpoint Federal is the name the coverage database gives the contractor for jurisdictions 6 and K, which CMS's jurisdiction pages list as National Government Services. The database also lists WPS's policy in most states, through a WPS Part A contract (number 05901); the regional contractors in the table are the ones that process Part B claims, which is how independent labs bill. Novitas is the only one of the seven without a vitamin D policy of its own: its "Assays for Vitamins and Metabolic Function" policy covers vitamin D alongside other vitamin and metabolic tests, and names no conditions for vitamin D in its text.
Every Medicare rate and coverage rule on this page was checked against the pages listed under Sources on November 16, 2026.
Frequently asked questions
Does Medicare cover a vitamin D test?
Only with a reason your regional contractor accepts in both its code list and its policy text, such as osteoporosis or chronic kidney disease stage 3 or worse. It never covers vitamin D testing as a screening test.
Does Medicare cover a vitamin D test for osteopenia?
All seven code lists include osteopenia codes, but only four policy texts name osteopenia: CGS, Palmetto GBA, WPS and First Coast. The Wellpoint Federal and Noridian texts do not, so in their regions ask whether another listed condition applies.
Will Medicare pay for a vitamin D test if I am tired all the time?
Not on that reason alone: fatigue (R53.83) is on none of the seven code lists or texts. A clinician evaluating fatigue may find another reason that is covered.
How often will Medicare pay for a vitamin D test?
It depends on the region. First Coast allows no more than three a year, Novitas up to three, WPS up to four for deficiency, and Palmetto GBA one recheck after 12 weeks and one more within a rolling 12 months. CGS, Wellpoint Federal and Noridian set no yearly count; see the table.
What does Medicare pay for a vitamin D test?
$29.60 to the lab for the 25-hydroxy test and $38.50 for the 1,25-dihydroxy test in 2026. You usually pay nothing for a covered diagnostic lab test on Original Medicare.